Patents Assigned to Orthogene LLC
  • Patent number: 8586074
    Abstract: Calcium sulfate composite particles for bone augmentation are disclosed. The composite particles are composed of aggregated calcium sulfate nanoparticles of a diameter from about 50 to about 800 nm, which include a mixture of calcium sulfate dihydrate and calcium sulfate hemihydrate. The composite particles have a diameter from about 200 to about 1,200 ?m, and a mean half-life no less than 18 days. Further disclosed is a bone grafting material for bone augmentation. The bone grafting material includes a mixture of the calcium sulfate composite particles and a second type of calcium sulfate particles having a particle diameter from about 2 to about 60 ?m, at a ratio from 1:1 to 4:1. The method of using the composite particles and the bone grafting material for bone augmentation is also disclosed.
    Type: Grant
    Filed: February 6, 2012
    Date of Patent: November 19, 2013
    Assignee: Orthogen, LLC
    Inventors: Sachin Mamidwar, Harold Alexander, John L. Ricci
  • Patent number: 7863352
    Abstract: Polymer containing calcium sulfate particles as an implant material are provided. The polymer containing calcium sulfate particles include a calcium sulfate compound coated with a therapeutic polymer containing salicylate, with a coating thickness from about 2 ?m to about 50 ?m. The therapeutic polymer in the particles is in a range from about 0.1% to about 22% (w/w). The resorption of the particles in vivo is from about four weeks to about twenty weeks. The polymer containing calcium sulfate particles can be used as an implant material for bone repairing and bone augmentation.
    Type: Grant
    Filed: November 20, 2008
    Date of Patent: January 4, 2011
    Assignee: Orthogen LLC
    Inventors: John L. Ricci, Harold Alexander, Bruce Hollander
  • Patent number: 7575780
    Abstract: A bone-growth stimulating composition for forming a resorbable implant, methods for making such a composition and a corresponding putty/paste material. In some embodiments of the invention, such a material includes a plurality of particles having a predetermined size and comprising a first calcium sulfate compound and a resorbable polymer in a predetermined weight ratio. Methods for making such a material include rotating calcium sulfate powder in a drum at a first predetermined drum speed, spraying of a resorbable polymer solution at a predetermined rate on the calcium sulfate powder over a predetermined period of time and drying the resulting particles. Such compositions allow resorption rates of the implant composition in vivo to be controlled, and my vary between eight and twenty-four weeks (for example), which can be matched to substantially correspond to a rate of bone growth in a particular application.
    Type: Grant
    Filed: March 6, 2006
    Date of Patent: August 18, 2009
    Assignee: Orthogen LLC
    Inventors: Harold Alexander, John L. Ricci, Sachin Mamidwar
  • Patent number: 7488761
    Abstract: An implant composition having controlled resorption rate in vivo for stimulating bone growth, a method of making the implant composition, and a kit of implant materials are disclosed. The implant composition includes a calcium sulfate compound, polymer containing particles, and a setting agent. The polymer is one or more poly(desaminotyrosyl-tyrosine alkyl ester carbonate). Upon setting, the calcium sulfate compound forms a matrix and the polymer containing particles settled within the matrix. The resorption rate of the implant composition in vivo can be controlled of between eight and twenty-four weeks, which substantially matches the rate of bone growth. The implant composition of the present invention can be used for the repair, augmentation, and other treatment of bone.
    Type: Grant
    Filed: July 14, 2004
    Date of Patent: February 10, 2009
    Assignee: Orthogen LLC
    Inventors: John L. Ricci, Harold Alexander, Bruce Hollander
  • Publication number: 20070149441
    Abstract: Methods for chemical modification of hyaluronic acid, formation of amine or aldehyde functionalized hyaluronic acid, and the cross-linking thereof to form hydrogels are provided. Functionalized hyaluronic acid hydrogels of this invention can be polymerized in situ, are biodegradable, and can serve as a tissue adhesive, a tissue separator, a drug delivery system, a matrix for cell cultures, and a temporary scaffold for tissue regeneration.
    Type: Application
    Filed: February 13, 2007
    Publication date: June 28, 2007
    Applicant: Orthogene LLC
    Inventors: Daniel Aeschlimann, Paul Bulpitt
  • Patent number: 7196180
    Abstract: Methods for chemical modification of hyaluronic acid, formation of amine or aldehyde functionalized hyaluronic acid, and the cross-linking thereof to form hydrogels are provided. Functionalized hyaluronic acid hydrogels of this invention can be polymerized in situ, are biodegradable, and can serve as a tissue adhesive, a tissue separator, a drug delivery system, a matrix for cell cultures, and a temporary scaffold for tissue regeneration.
    Type: Grant
    Filed: October 6, 2003
    Date of Patent: March 27, 2007
    Assignee: Orthogene LLC
    Inventors: Daniel Aeschlimann, Paul Bulpitt
  • Patent number: 6630457
    Abstract: Methods for chemical modification of hyaluronic acid, formation of amine or aldehyde functionalized hyaluronic acid, and the cross-linking thereof to form hydrogels are provided. Functionalized hyaluronic acid hydrogels of this invention can be polymerized in situ, are biodegradable, and can serve as a tissue adhesive, a tissue separator, a drug delivery system, a matrix for cell cultures, and a temporary scaffold for tissue regeneration.
    Type: Grant
    Filed: September 18, 1998
    Date of Patent: October 7, 2003
    Assignee: Orthogene LLC
    Inventors: Daniel Aeschlimann, Paul Bulpitt